Clinical Trials

Showing 41 - 60 of 512 trials
Title Investigatorsort icon Disease(s)
A Phase I Study of BMS-986016 Alone and with Nivolumab in Patients with Advanced Solid Tumors
[Protocol 14-010]
Callahan, Margaret
  • Solid Tumors
A Phase I/II Study of Nivolumab Alone and with Ipilimumab in Patients with Advanced or Metastatic Solid Tumors
Relapsed/Refractory
[Protocol 13-187]
Callahan, Margaret
  • Breast Cancer
  • Hepatobiliary
    • Pancreatic Cancer
  • Lung Cancer, Non-Small Cell
  • Upper Gastrointestinal
    • Gastric Cancer
    • Pancreatic Cancer
A Pilot Trial of PET Imaging with (89)Zr-DFO-Trastuzumab in Esophagogastric Cancer
[Protocol 13-165]
Carrasquillo, Jorge
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
Biological, Behavioral, and Sociodemographic Characteristics of Long-Term Survivors of Ovarian Cancer
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-224]
Carter, Jeanne
  • Ovarian Cancer
  • Survivorship
A Study of Non-Hormonal Vaginal Moisturizer in Hormone Receptor-Positive Postmenopausal Cancer Survivors
[Protocol 12-232]
Carter, Jeanne
  • Breast Cancer
  • Survivorship
A Phase I Study of Dasatinib and Ipilimumab for Patients with Advanced GIST or Other Sarcomas
[Protocol 12-083]
Carvajal, Richard
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase II Study of RAD001 (Everolimus) and Pasireotide (SOM230)) in Patients with Advanced Uveal Melanoma
[Protocol 10-123]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye
A Phase II Study of Vorinostat for Metastatic Uveal Melanoma
[Protocol 12-027]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye
Acupuncture for Chronic Lymphedema After Breast Cancer Treatment
[Protocol 12-210]
Cassileth, Barrie
  • Breast Cancer
  • Quality of Life
  • Survivorship
A Study Comparing Reduced-Intensity Allogeneic Stem Cell Transplantation with Best Supportive Therapy in Older Patients with Myelodysplastic Syndromes
[Protocol 14-123]
Castro-Malaspina, Hugo
  • Hematology
    • Myelodysplastic Syndrome
A Phase I Study of Hepatic Arterial Infusion with Floxuridine, Dexamethasone, and Gemcitabine after Surgery for Liver Cholangiocarcinoma
[Protocol 13-148]
Cercek, Andrea
  • Hepatobiliary
    • Liver Cancer
A Phase II Study of MPDL3280A in Patients with PD-L1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
[Protocol 14-024]
Chaft, Jamie
  • Lung Cancer, Non-Small Cell
A Phase II Study Comparing Three Months versus Two Years of Afatinib Therapy after Surgery for Patients with Stage I-III Non-Small Cell Lung Cancer
[Protocol 13-096]
Chaft, Jamie
  • Lung Cancer, Non-Small Cell
A Phase III Study of Nivolumab versus Standard Chemotherapy as Initial Treatment for Metastatic or Recurrent Non-Small Cell Lung Cancers that Express PD-L1
[Protocol 14-095]
Chaft, Jamie
  • Lung Cancer, Non-Small Cell
A Phase II Study of MEDI4736 in Patients with Stage IIIB-IV Non-Small Cell Lung Cancer Containing the PD-L1 Protein
[Protocol 14-103]
Chaft, Jamie
  • Lung Cancer, Non-Small Cell
Molecular Mechanisms of Clinical Resistance to Anti-HER2 Therapy Among Patients with HER2-Amplified Breast Cancer
[Protocol 06-163]
Chandarlapaty, Sarat
  • Breast Cancer
A Phase II Clinical Trial of Trametinib plus GSK2141795 in Patients with Melanoma Containing a Normal BRAF Gene
[Protocol 13-258]
Chapman, Paul
  • Melanoma
A Phase II Study of Dacarbazine with and without Selumetinib to Treat Metastatic Uveal Melanoma
[Protocol 14-033]
Chapman, Paul
  • Melanoma
    • Melanoma of the Eye
A Phase II Study of LGX818 Given in a Pulsatile Schedule to Patients with Stage III or IV Melanoma with a BRAF Mutation
[Protocol 13-053]
Chapman, Paul
  • Melanoma
A Phase II Study of Crizotinib in Patients with High-Risk Uveal Melanoma
[Protocol 14-063]
Chapman, Paul
  • Melanoma
    • Melanoma of the Eye